With demand vastly outweighing supply, President Biden should make sure the two treatments okayed by the Food and Drug Administration, Merck’s Molnupiravir and Pfizer’s Paxlovid, go where they’re needed most, the New York Democrat and Senate Majority Leader said.
More News
Readers sound off on apolitical policing, genocidal violence in Darfur and Duane Eddy
Person falls to death from stands during Ohio State graduation
Woman beaten on Brooklyn train after intervening in assault on another woman